Company Profiles

driven by the PitchBook Platform

TheraVasc

Description

Developer of therapies and treatments for chronic medical diseases. The company engages in research and development of re-purposed drugs using an oral formulation of sodium nitrite for the treatment of vascular disorders.

2009

Founded

PRIVATE

Status

Series B

Latest Deal Type

$470k

Latest Deal Amount

$5.04M

Total Amount Raised

10

Investors

Description

Developer of therapies and treatments for chronic medical diseases. The company engages in research and development of re-purposed drugs using an oral formulation of sodium nitrite for the treatment of vascular disorders.

Website:

www.theravasc.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

10000 Cedar Avenue MS Suite 1 Cleveland, OH 44106United States +1 (318) 349-3851
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore TheraVasc's full profile, request a free trial.

TheraVasc Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

TheraVasc Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

TheraVasc Investors (10)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Great Lakes Innovation and Development EnterpriseAccelerator/IncubatorMinority000 0000000 0000
Innovation Fund of Northeast OhioAccelerator/IncubatorMinority000 0000000 0000
JumpStartAccelerator/IncubatorMinority000 0000000 0000
North Coast Angel FundAngel GroupMinority000 0000000 0000
Ohio Tech AngelsAngel GroupMinority000 0000000 0000
Great Lakes Innovation and Development Enterprise Accelerator/Incubator
Innovation Fund of Northeast Ohio Accelerator/Incubator
JumpStart Accelerator/Incubator
North Coast Angel Fund Angel Group
Ohio Tech Angels Angel Group

TheraVasc Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Chris Kevil Ph.DCo-Founder, Chief Scientific Advisor & Chief Scientific Officer
David LeferChief Scientific Adviser
Douglas Flanagan Ph.DFormulation Supervisor
James BoudreauxCo-Founder and Formulation Advisor
Chris Kevil Ph.D Co-Founder, Chief Scientific Advisor & Chief Scientific Officer
David Lefer Chief Scientific Adviser
Douglas Flanagan Ph.D Formulation Supervisor
James Boudreaux Co-Founder and Formulation Advisor

TheraVasc Board Members (4)

NameRepresentingRoleSinceContact
Info
Amol SoinTheraVascChief Medical Officer, Chief Clinical Advisor & Board Member000 0000
Bill KilroySelfBoard Member000 0000
John HustonOhio Tech AngelsCo-Founder000 0000
Kyle Chan Ph.DSelfBoard Member000 0000
Amol Soin Chief Medical Officer, Chief Clinical Advisor & Board Member TheraVasc
Bill Kilroy Board Member Self
John Huston Co-Founder Ohio Tech Angels
Kyle Chan Ph.D Board Member Self
Request full access to PitchBook